Medical and Pharmaceutical Keensight Capital takes majority stake in breath analysis device maker "Quick and non-invasive breath analysis is the new blood test," says Bedfont Scientific Rowan Dunne11 hours ago
Sleep ResMed Q4 earnings show considerable upside for sleep tech company In Q4, ResMed's revenue enjoyed a 4 per cent bump to $914.7 million, an 8 per cent increase over the previous year. Joseph MortonAugust 25, 2022